Abstracts

Virological Factors Associated With Outcome of Dual MVC/RAL Therapy (ANRS-157 Trial)

Background: ROCnRAL ANRS-157 was a single-arm study designed to evaluate a switch to a maraviroc (MVC) 300 mg bid plus raltegravir (RAL) 400 mg bid regimen in virologically suppressed patients with lipohypertrophy, and R5-tropic B or CRF02_AG HIV-1 subtype determined on DNA by Sanger sequencing. In these long-term antiretroviral experienced patients (n=44), the combo MVC/RAL…

D-dimer Doesn’t Return to Pre-HIV Levels After Therapy and Is Linked With HANA Events

Background: Biomarkers of inflammation increase with HIV infection, and decline with therapy (ART). While it has been proposed that these markers fail to decline to levels that existed before HIV seroconversion (SC), this has never been directly demonstrated. Moreover, it is unknown whether this “residual” inflammation is associated with future HIV Associated Non AIDS (HANA)…

Virological Responses to Lamivudine and Emtricitabine in the Nationwide ATHENA Cohort

Background: Lamivudine (3TC) and emtricitabine (FTC) are considered interchangeable in recommended combination antiretroviral therapies (cART) including tenofovir (TDF) with a non-nucleoside reverse transcriptase inhibitor (NNRTI) or boosted protease inhibitor (PI). The evidence for equivalent efficacy of 3TC and FTC in cART is inconsistent and data from randomized clinical trials that directly compare FTC and 3TC…

Prevalence and Risk Factors of Multiple Micronutrient Deficiencies Pre- and Post-ART

Background: Micronutrient deficiencies pose a special risk among immune suppressed HIV-infected adults resulting in an accelerated disease progression even when on antiretroviral therapy (ART). The objective of this study was to describe the prevalence and risk factors of multiple micronutrient deficiencies among ART-naïve HIV-infected adults from 9 countries and to test the hypothesis that micronutrient…

Detection of HIV RNA and DNA in Anal Swabs of HIV Infected Men Having Sex With Men

Background: Unprotected anal intercourse is high-risk behavior for acquiring HIV-infection. The transmission risk depends on plasma viral loads and concomitant sexual transmitted infections (STI). However, the effect of STI and antiretroviral therapy (ART) on the detection of HIV in the anal tract has not been scrutinized in detail. Methods: 110 HIV-positive MSM, were recruited for…

Reference Curves for CD4 Response to Antiretroviral Treatment in HIV-1–Infected Naïve Patients

Background: There is no consensus on how CD4+ T cell should increase in early response to combination antiretroviral treatment (cART). We provide references for CD4+ T cell increases following cART initiation in HIV-1 infected naïve patients with a good virological response at 6 months. Methods: All individuals from the 33 cohorts participating in the Collaboration…

Comparing Immunological Failure Definitions, Using Tanzanian National HIV Data

Background: Rates of first-line treatment failure and switches to second-line therapy are key indicators of national antiretroviral therapy (ART) programmes, but there is little consensus on the immunological failure (IF) criteria to be used in the absence of virological monitoring, which remains too expensive for most African national programmes. Methods: Using routinely-collected data from the…

Rapid Progression Hinders the Recovery of CD4 + T Cells Following Initiation of cART

Background: We aimed to compare trends in CD4+ T-cell recovery after combination antiretroviral therapy (cART) initiation and proportion of patients achieving optimal CD4+ T-cell restoration (counts ≥500 cells/µl) after 12, 36 and 60 months of viral suppression between rapid (RP) and non-rapid progressors (non-RP). Methods: We included HIV-1 seroconverters (SC) from CASCADE who initiated cART…

Increase in CD4 Counts at Presentation to ART Care Among Urban HIV Clinics in Uganda

Background: In resource-limited settings, the increased availability of HIV testing services, scale-up of antiretroviral therapy (ART), and revised ART initiation guidelines has led to increased accessibility to HIV care. We hypothesized that HIV-infected persons are seeking care earlier compared with the era of initial ART roll-out in sub-Saharan Africa. We investigated the median CD4 count…